These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34649705)

  • 1. Preventing Bleeding With Direct-Acting Oral Anticoagulants.
    Schwartz JB; Kogan SC; Fang MC
    J Am Coll Cardiol; 2021 Oct; 78(16):e127. PubMed ID: 34649705
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply: Preventing Bleeding With Direct-Acting Oral Anticoagulants.
    Gómez-Outes A; Alcubilla P; Lecumberri R; Calvo-Rojas G; Vargas-Castrillón E
    J Am Coll Cardiol; 2021 Oct; 78(16):e129. PubMed ID: 34649706
    [No Abstract]   [Full Text] [Related]  

  • 3. Direct oral Xa inhibitors versus warfarin in patients with cancer and atrial fibrillation: a meta-analysis.
    Casula M; Fortuni F; Fabris F; Leonardi S; Gnecchi M; Sanzo A; Greco A; Rordorf R
    J Cardiovasc Med (Hagerstown); 2020 Aug; 21(8):570-576. PubMed ID: 32628422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of gastrointestinal bleeding with direct oral anticoagulants: a systematic review and network meta-analysis.
    Burr N; Lummis K; Sood R; Kane JS; Corp A; Subramanian V
    Lancet Gastroenterol Hepatol; 2017 Feb; 2(2):85-93. PubMed ID: 28403994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Warfarin and Newer Agents: What the Oral Surgeon Needs to Know.
    Steed MB; Swanson MT
    Oral Maxillofac Surg Clin North Am; 2016 Nov; 28(4):515-521. PubMed ID: 27624772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthcare resource utilization and costs among patients with direct oral anticoagulant or warfarin-related major bleeding.
    Xu Y; Schulman S; Dowlatshahi D; Holbrook AM; Simpson CS; Shepherd LE; Wells PS; Giulivi A; Gomes T; Mamdani M; Frymire E; Khan S; Johnson AP;
    Thromb Res; 2019 Oct; 182():12-19. PubMed ID: 31434018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The New Direct-Acting Oral Anticoagulants Need to be Monitored!
    Jelliffe R; Christians U
    Ther Drug Monit; 2020 Jun; 42(3):357-359. PubMed ID: 32427780
    [No Abstract]   [Full Text] [Related]  

  • 8. How can we reverse bleeding in patients on direct oral anticoagulants?
    Crowther M; Cuker A
    Kardiol Pol; 2019; 77(1):3-11. PubMed ID: 30338501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycemic status and risks of thromboembolism and major bleeding in patients with atrial fibrillation.
    Chan YH; Chuang C; Chan CC; Lee HF; Huang YC; Huang YT; Chang SH; Wang CL; Chao TF; Kuo CT; Yeh YH; Chen SA
    Cardiovasc Diabetol; 2020 Mar; 19(1):30. PubMed ID: 32156277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four-factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors versus Warfarin in Life-threatening Bleeding.
    Rech MA; Masic D; Hammond DA
    West J Emerg Med; 2021 Feb; 22(2):163-169. PubMed ID: 33856296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world Comparisons of Direct Oral Anticoagulants for Stroke Prevention in Asian Patients with Non-valvular Atrial Fibrillation: a Systematic Review and Meta-analysis.
    Chan YH; Lee HF; Chao TF; Wu CT; Chang SH; Yeh YH; See LC; Kuo CT; Chu PH; Wang CL; Lip GYH
    Cardiovasc Drugs Ther; 2019 Dec; 33(6):701-710. PubMed ID: 31745687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse Drug Reactions and Cutaneous Manifestations Associated With Anticoagulation.
    Vu TT; Gooderham M
    J Cutan Med Surg; 2017; 21(6):540-550. PubMed ID: 28639463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct oral anticoagulants and the bleeding patient.
    Wood B; Sholzberg M; Ackery A
    CMAJ; 2016 Feb; 188(3):215. PubMed ID: 26464134
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost-Effectiveness Analysis of Direct-Acting Oral Anticoagulants for Stroke Prevention in Thai Patients with Non-Valvular Atrial Fibrillation and a High Risk of Bleeding.
    Rattanachotphanit T; Limwattananon C; Waleekhachonloet O; Limwattananon P; Sawanyawisuth K
    Pharmacoeconomics; 2019 Feb; 37(2):279-289. PubMed ID: 30387074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis.
    See LC; Lee HF; Chao TF; Li PR; Liu JR; Wu LS; Chang SH; Yeh YH; Kuo CT; Chan YH; Lip GYH
    Cardiovasc Drugs Ther; 2021 Oct; 35(5):975-986. PubMed ID: 33211254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and effectiveness of oral factor Xa inhibitors versus warfarin in nonvalvular atrial fibrillation patients at high-risk for falls.
    Miao B; Alberts MJ; Bunz TJ; Coleman CI
    J Thromb Thrombolysis; 2019 Oct; 48(3):366-372. PubMed ID: 31228038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Throwing it in reverse: An update on reversal of oral factor Xa inhibitors.
    Gilbert BW; Reeder JA; Alkhalifah MA; Moran DA; Corvino MA
    Am J Emerg Med; 2019 Oct; 37(10):1978-1980. PubMed ID: 30987915
    [No Abstract]   [Full Text] [Related]  

  • 18. Andexanet alfa for reversal of factor Xa inhibitors: a critical review of the evidence.
    Abdulrehman J; Eikelboom JW; Siegal DM
    Future Cardiol; 2019 Nov; 15(6):395-404. PubMed ID: 31668083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Less abnormal uterine bleeding with dabigatran than warfarin in women treated for acute venous thromboembolism.
    Huisman MV; Ferreira M; Feuring M; Fraessdorf M; Klok FA
    J Thromb Haemost; 2018 Sep; 16(9):1775-1778. PubMed ID: 29974611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta-analysis of randomized controlled trials.
    Chai-Adisaksopha C; Hillis C; Isayama T; Lim W; Iorio A; Crowther M
    J Thromb Haemost; 2015 Nov; 13(11):2012-20. PubMed ID: 26356595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.